PCI (percutaneous coronary intervention)

PROCEDURE3 trials

Sponsors

Helse Stavanger HF, R&D Cardiologie, NAUSICA Investigators

Conditions

AnticoagulantsAtrial FibrillationHeart Failure, CongestivePatency of the Radial ArteryPlatelet Aggregation InhibitorsStents

Phase 4

WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)

CompletedNCT00769938

R&D CardiologieAnticoagulants, Atrial Fibrillation, Platelet Aggregation Inhibitors +1

Start: 2008-12-31End: 2012-08-31Updated: 2013-01-15

Unknown Phase

MR, Myocardial Infarct and Heart Failure

CompletedNCT00465868

Helse Stavanger HFHeart Failure, Congestive

Start: 2004-12-31End: 2007-05-31Updated: 2015-07-28

Novel Angioplasty Using Coronary Accessor

CompletedNCT00815997

NAUSICA InvestigatorsPatency of the Radial Artery

Start: 2009-01-01End: 2010-12-31Updated: 2019-05-06

Related Papers

Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial

EuroIntervention2015-08-0150 citations

Comparison of frequency of radial artery occlusion after 4Fr versus 6Fr transradial coronary intervention (from the Novel Angioplasty USIng Coronary Accessor Trial).

2014-04-0122 citations

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

2013-02-131142 citations